Biopharma News

Aug 06, 2013
By BioPharm International Editors
A loan from the Province of Nova Scotia will support Immunovaccine's clinical studies through 2016.
Aug 06, 2013
By BioPharm International Editors
The licensed cell line combines BioWa's engineered glycosylation Potelligent Technology with Lonza's GS Gene Expression System.
Aug 06, 2013
By BioPharm International Editors
uniQure B.V. announced it has commenced build-out of a 55,000 ft2 US manufacturing plant in Lexington, Mass.
Jul 23, 2013
By BioPharm International Editors
Immunocore Limited has entered into a partnership with GlaxoSmithKline for multiple novel targets not addressable using antibody-based technologies.
Jul 02, 2013
By BioPharm International Editors
The companies agree to jointly develop and promote MOR202, an oncology mAb in a deal potentially valued at more than $800 million.
Jul 02, 2013
By BioPharm International Editors
The $1-billion deal includes select parts of Merck?s manufacturing site in Oss, The Netherlands and Sioux City, Iowa as well as 11 finished products.
Jun 06, 2013
By BioPharm International Editors
FDA Discovers Microbial Contamination in Compound Pharmacy Products
Jun 05, 2013
By BioPharm International Editors
Modular containment room at Belfast facility allows studies of biologics and vaccines.
Jun 05, 2013
By BioPharm International Editors
The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
Jun 04, 2013
By BioPharm International Editors
-
native1_300x100
lorem ipsum